SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-062239
Filing Date
2024-03-07
Accepted
2024-03-07 16:34:44
Documents
6
Effectiveness Date
2024-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d803104ds8.htm S-8 49749
2 EX-5.1 d803104dex51.htm EX-5.1 12302
3 EX-23.2 d803104dex232.htm EX-23.2 1589
4 EX-FILING FEES d803104dexfilingfees.htm EX-FILING FEES 20362
5 GRAPHIC g803104dsp7.jpg GRAPHIC 4411
6 GRAPHIC g803104dsp7a.jpg GRAPHIC 2811
  Complete submission text file 0001193125-24-062239.txt   95390
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277748 | Film No.: 24730678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)